BridgeMD
Prevention study for Cervical Cancers
Official title Use Misoprostol to Optimize Prevention of Cervical Cancer
ClinicalTrials.gov ID: NCT06669533
What this study is testing
What is Misoprostol?
Misoprostol is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for cervical cancers.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Diagnosis of Type 3 TZ confirmed on exam prior to randomization
- Age 25 years or older
You likely can't join if
- With Type 1 or 2 TZ prior to randomization
- Currently pregnant
- History of hysterectomy
- Any cancerous lesions
- Active cervicitis
The study team makes the final eligibility decision.
Where it's taking place
- Yaoundé, Center Region, Cameroon
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yaoundé, Center Region, Cameroon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.